Cargando…
Autocrine motility factor and its receptor expression in musculoskeletal tumors
Management of aggressive malignant musculoskeletal tumors is clinically challenging and awaits the identification of regulator(s) that can be therapeutically used to improve patient outcome. Autocrine motility factor (AMF), a secreted cytokine, is known to alter the bone microenvironment by linking...
Autores principales: | Nakajima, Kosei, Raz, Avraham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574284/ https://www.ncbi.nlm.nih.gov/pubmed/33101887 http://dx.doi.org/10.1016/j.jbo.2020.100318 |
Ejemplares similares
-
Amplification of autocrine motility factor and its receptor in multiple myeloma and other musculoskeletal tumors
por: Nakajima, Kosei, et al.
Publicado: (2020) -
Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor
por: NAKAJIMA, KOSEI, et al.
Publicado: (2012) -
Galectin-3: an immune checkpoint target for musculoskeletal tumor patients
por: Nakajima, Kosei, et al.
Publicado: (2020) -
Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer.
por: Hirono, Y., et al.
Publicado: (1996) -
Expression of Gp78/Autocrine Motility Factor Receptor and Endocytosis of Autocrine Motility Factor in Human Thyroid Cancer Cells
por: Wiseman, Sam M, et al.
Publicado: (2019)